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The wide diversity of the marine environment has been an important resource for the discovery of new 
bioactive agents from marine organisms. The aim of this study was to obtain protein extracts from the 
clam Chione fluctifraga and determine its antiproliferative activity against cervical and breast cancer 
cells. The extracts were obtained by ammonium sulfate fractionation, gel filtration and ion exchange 
chromatography. Antiproliferative activity was evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide assay (MTT). The results showed that 3F3 had antiproliferative effect 
against HeLa and MDA-MB-231 cell lines with IC50 values of 138.035 and 157.19 µg/ml, respectively, and 
2F2 showed IC50 values of 67.46 µg/ml on HeLa cells. These results suggest that protein extracts from 
C. fluctifraga might be potential anticancer agents. 
 





Cancer is a worldwide health issue; it is not just one 
disease but a variety of different diseases, which have in 
common uncontrolled cell proliferation. There are more 
than 100 different types of cancer, most of them take the 
name of the organ or cell in which they begin to grow 
(Hawkins, 1992; Martinez et al., 2003). Breast and 
cervical cancer are the main cancer related cause of 
death in women around the world. The high prevalence of 
these types of cancer is due to a lack of strategies that 
allow detection at early cancer stages (Palacio-Mejía et 
al., 2009; Gök et al., 2011). Chemotherapy is the most 
commonly used treatment against cancer, however some
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patients develop resistance against the drugs and this 
has become a major problem in the past years. 
Resistance to treatment can be caused by a large variety 
of factors, which include individual variations between 
patients and genetic differences among tumor cells 
(Gottesman, 2002; Jordan and Wilson, 2004; Bhutia and 
Maiti, 2008). The discovery of new compounds from 
natural sources has been very important in 
pharmaceutical science research. The past decade has 
seen an increase in the number of compounds obtained 
from the screening of diverse marine invertebrates, such 
as soft corals, tunicates and mollusks, that are advancing 
to preclinical trials (Liang et al., 2008; Simmons et al., 
2005; Amador, 2003; Bhatnagar and Kim, 2010). 
Examples of anticancer agents extracted from marine 
organisms include bryostatin-1, a macrocyclic lactone 
from Bugula neritine, with antitumor activity; ziconotide, a 
peptide from cone snail, is an N-type calcium-channel 
blocker in chronic pain treatment; ectenaisdin 743 is a 
tetrahydroisoquinolone alkaloid, isolated from 
Ectinascidia turbinate, with cytotoxic activity. It has been 
previously reported that the peptide dolastatin, obtained 
from the marine mollusk Dollabella auricularia, possesses 
an impressive growth inhibition of cancer cells. Another 
example is Kahalalide F, a cyclic depsipeptide obtained 
from Elysia rufescens; this peptide shows antitumor 
activity against colorectal, lung and prostate cancer cells, 
being lysosomes the cellular target (Haefner, 2003; 
Amador, 2003; Aneiros and Garateix, 2004; Faircloth and 
Cuevas, 2006; Bhatnagar and Kim, 2010). 
Many peptides with different biological activities such 
as antioxidant (Wenyan et al., 2012),  immune-regulatory 
(Lixin et al., 2005),  antihyperglycemia and 
antihyperlipemia activity (Tsai et al., 2008) have been 
isolated from the clam Meretrix meretrix; polypeptide 
Mer2, MGP0501 and MGP0405 inhibits cell proliferation of 
several cancer cell lines; Mere-15 shows antitumor 
activity in vitro and in vivo; the protein (MML) shows 
growth inhibition in several cancer cell lines such as 
breast, colon and hepatic (Leng et al., 2005; Ning et al., 
2009; Wang et al., 2012). Two peptides, 18 and 16 kDa, 
with cytotoxic activity in vitro against HeLa cells have 
been purified from Arca subcrenata (Song et al., 2008). 
The Gulf of California has a great diversity of clams, such 
as the black clam (Chione fluctifraga), that represent a 
popular seafood and a very important income source for 
the community (Martinez-Cordova and Martinez-Porchas, 
2006). The aim of the present study was to evaluate the 
capability of C. fluctifraga’s protein extract to inhibit the 
cellular growth on HeLa and MDA-MB-231 cultured cells.   
 
 




The clams (C. fluctifraga) were obtained from the experimental  unit  




of the University of Sonora (Kino Bay, Sonora). All the reagents 
were obtained from Sigma-Aldrich (St. Louis, MO, USA).  
 
 
Preparation of the crude extract  
 
The clams were cut into small pieces and homogenized with 0.01 M 
phosphate buffer (0.1 M NaCl, pH 7.2) in a 1:3 ratio (w/v). The 
homogenate was centrifuged at 3000 x g. The supernatant was 
fractionated by ammonium sulfate precipitation up to 60% 
saturation. After 12 h of stirring the precipitate was collected by 
centrifugation (3000 x g, 10 min) and the pellet was suspended in 
phosphate buffer and collected as the crude extract.   
 
 
Preparation of protein extract 
 
The crude extract was passed through a Sephadex G-25 column 
(1.5 × 50 cm) pre-equilibrated with 0.01 M phosphate buffer (0.1 M 
NaCl, pH 7.2) at a flow rate of 1 ml/min and the absorbance was 
monitored at 280 nm. The fraction collected was dialyzed against 
0.025 M Tris-HCl and then loaded onto a HiPrep 16/10 Q XL 
column (BioRad) pre-equilibrated with 0.025 M Tris-HCl pH 8.2. The 
column was eluted with a linear gradient 0 to 1 M NaCl prepared in 
Tris-HCl buffer at a flow rate of 1 ml/min, each fraction was 
collected at a volume of 5 ml and detection was performed at 280 
nm. Fractions were lyophilized then dialyzed and antiproliferative 
activities were determined.  
 
 
Measurement of protein content  
 
The protein concentration was measured by the BCA method using 






The extraction process was monitored by electrophoresis tricine-
SDS-PAGE (Schägger, 2006) using a Bio-Rad Mini-Protean II 
electrophoresis unit (Bio-Rad, CA, USA) with an acrylamide 
concentration of 16% for the running gel. The protein bands were 





The breast cancer cell (MDA-MB-231), cervical cancer cell (HeLa) 
and a human retinal pigment epithelial cell line (ARPE-19) were 
obtained from American Type Culture Collection (Rockrville, MD). 
HeLa and ARPE-19 cell were grown in Dulbecco´s Modified Eagle 
Medium (DMEM) supplemented with 10% fetal bovine serum 
(GIBCO, BRL, Grand Island, NY), 1% penicillin-streptomycin and 
1% gentamicin; MDA-MB-231 was grown in DMEM supplemented 
with 15% fetal bovine serum, 2 mM glutamine, 1% penicillin-
streptomycin, 1% gentamicin and 1% non-essential amino acids 
(SIGMA-Aldrich, St. Louis, MO, USA) and were maintained at 37°C 
under humidified atmosphere with 5% CO2.  
 
 
Antiproliferative assay   
 
MDA-MB-231, HeLa and ARPE-19 cells were cultured in a 96 wells 
microplate (1 x 104 cell/ml) for 24 hours; then 50 µl of the extracts 
were added in serial concentrations, PBS or Cisplatin as controls, 
and incubated for 48 h. At the end of the incubation period, 10 µl of  














Figure 1. Fractionation of crude extract by gel filtration chromatography on a Sephadex G-
25 column. Column specification: 1.5 x 50 cm; the elution was performed with 0.1M 




solution (SIGMA-Aldrich, St. Louis, MO, USA) were added to each 
well and the microplate was incubated for 4 h to allow the formation 
of formazan by the viable cell. The formazan crystals were 
dissolved in 150 µl of solubilization solution. The absorbance was 
read on an ELISA reader (Beckman Coulter AD 340) at 570 nm. 
The percentage of growth inhibition was calculated as [(values from 
experimental conditions) – (values from control conditions)] × 100 / 





The experimental data were expressed as the mean ± standard 
deviation. Statistical analysis was carried out using the GraphPad 
PRISM 6 program (GraphPad Software, Inc., San Diego, CA), 




RESULTS AND DISCUSSION 
 
Marine organisms represent a large source of new 
compounds with biological activities. Direct extraction is 
one way to obtain bioactive compounds from marine 
organisms; this approach is widely used for isolated and 
purified biologically active peptides (Chen et al., 2013). 
Figure 1 shows the crude extract’s chromatogram. Three 
fractions were obtained after passing the crude extract 
through the Sephadex column. The separation is given 
based on the size, the high molecular weight proteins 
were obtained in the first fraction and afterwards the low 
molecular weight ones. The fractions that resulted (F1, 
F2, and F3) from gel filtration chromatography were 
separated by ion-exchange chromatography through 
elution with a NaCl gradient on a HiPrep 16/10 QXL 
column, ten fractions were obtained as follows: four 
fractions from F1, three fractions from F2 and three 
fractions from F3 (Figure 2). Antiproliferative activity of all 
fractions was tested using the MTT assay, a well-
established in vitro model for citotoxicity against cancer 
cell lines that has been used as a conventional technique 
for the screening of new compounds with antiproliferative 
activity (Song et al., 2008). F1 showed a antiproliferative 
effect of 87% of over MDA-MB-231 cell and 43.17% over 
HeLa cell. F3 shows inhibition of the cellular growth of 
64.36 and 70% on HeLa and MDA-MB-231 cell, 
respectively (Figure 3). When a high concentration of the 
extract is required to inhibit the cellular growth on 50% of 
the population, it is considered a low cytotoxicity (Hsu et 
al., 2010). The concentrations used ranged from 0.054 to 
1.97 mg/ml, inhibition on cancer cell line has been 
reported with 1 mg/ml of extracts (Picot et al., 2006; 
Liang et al., 2008). The fractions did not inhibit cellular 
proliferation beyond 60% on the human retinal pigment 
epithelial cells (ARPE-19). Ten fractions were obtained 
by ion-exchange chromatography, on the antiproliferative 
evaluation of these samples (Table 1), the fraction 3F3 
showed to inhibit the proliferation of HeLa and MDA-MB-
231 cell with IC50 values of 138.035 and 157.19 µg/ml 
respectively and 2F2 fraction showed IC50 values of 
















Figure 2. Fractionation by anion exchange chromatography on a 
HiPrep 16/10 QXL column. The elution was performed with a linear 
gradient of NaCl (0-1 M) in 25 mM Tris-HCl buffer at a flow rate of 
1ml/min. The elution was monitored at 280 nm. F1: Fraction 1 from gel 
filtration chromatography; F2: Fraction 2 from gel filtration 




reported IC50 values of 84.9 and 215.3 µg/ml over A549 
and CCRF-CEM cells, for Syngnathus acus’s protein 
purified by ion-exchange cromatography; from A. 
subcrenata two fractions have shown cytotoxic activity 
against HL-60 (IC50: 123.2 µg/ml) and HeLa cells (IC50: 
38.2 µg/ml) (Song et al., 2008). 
Several biologically active peptides from marine 
organisms have been identified and have shown different 
activities including antioxidant, antimicrobial, antiproli-
ferative and antihypertensive actions (Kim et al., 2013). 
Some of these compounds are in the process of entering 
clinicals trials. Peptides from marine sources (Jaspamide, 
aplidine, didemnin, MML, Mere 15 and dolastatin) induce 
cell death with different mechanisms, including apoptosis, 
disruption of microtubular function; interaction with 
tubulin, alteration of microtubule assembly, or angioge-
nesis inhibition (Bai et al., 1990; Zheng et al., 2011). Also 
some of these compunds can bind the vinca alkaloids or 
the colchine-binding domain inhibiting the polimerization 
of microtubules (Simmons et al., 2005; Amador, 2003). 
Several bands with molecular weights between 45 and 18 
kDa were observed in the electrophoresis gel (Figure 4). 
Several compounds derived from marine organisms that 
have been evaluated on pre-clinical and clinical trials as 
potential anticancer drug are low molecular weight 
compounds (Ning et al., 2009).  
Cyplisin, a 56 kDa protein isolated from Aplysia 
punctate, has shown citotoxicity against several cancer 
cell lines; MML, a 40 kDa protein from M. meretrix, has 










Figure 3. The inhibitory effect of fractions obtained by gel filtration chromatography. The 
cancer cell lines were treated with the indicated concentrattion of protein and cell proliferation 
was determinated by MTT assay. A: Fraction 1; B: Fraction 2; C: Fraction 3. 
 
 
Table 1. Antiproliferative activity of fractions obtained by anion 





ARPE-19 HeLa MDA-MB-231 
1 F1 345.76 ± 0.0092 ND 105.89 ± 0.036* 
1 F2 174.42± 0.0074 ND 101.83  ± 0.0068* 
1 F3 281.29 ± 0.082 ND 150.35 ± 0.0005 
1 F4 497.84 ± 0.167 ND 187.02 ± 0.0066* 
2F1 260.18 ± 0.022 227.18 ± 0.13 ND 
2F2 146.22 ± 0.030 67.46 ± 0.0026* ND 
2F3 235.94 ± 0.053 143.02 ± 0.0024* ND 
3F1 1339.91 ± 1.42 119.35 ± 0.013 1667.70 ± 1.075 
3F2 1201.5 ±  0.21 155.09 ± 0.032* 186.67 ± 0.057* 
3F3 240.54 ± 0.022 138.035 ± 0.0017* 157.19 ± 0.052 
 
ND: No determinate; 1F1: Fraction 1 from F1; 1F2: Fraction 2 from F1; 
1F3: Fraction 3 from F1; 1F4: Fraction 4 from F1; 2F1: Fraction 1 from 
F2; 2F2: Fraction 2 from F2; 2F3: Fraction 3 from F2; 3F1: Fraction 1 
from F3; 2F3: Fraction 2 from F3; 3F3: Fraction 3 from F3. (*) 
Significant difference between the normal cell and cancer cell line at 




















Figure 4. Tricine-SDS-PAGE of fractions obtained by anion exchange chromatography; protein bands were detected by silver stain. 
Lane A: Low range molecular weight marker; B: Fraction 1 from F1; C: Fraction 2 from F1; D: Fraction 3 from F1; E: Fraction 4 from 




apparently increasing the permeability of the cell 
membrane and inhibiting tubulin polymerization. Also, 
peptides with antiproliferative activity, such as MGP0405 
and MGP0501 (9.6 and 15.8 kDa, respectively), have been 
reported (Hoarau et al., 2002; Lixin et al., 2005; Nakano 
et al., 2006; Takahashi et al., 2008; Zheng et al., 2011; 
Wang et al., 2012). Takahashi et al. reported a protein 
with antimicrobial activity of 58 kDa from clam (Ruditapes 
philippinarum) and Hoarau found fractions of 20 to 28 
kDa with detoxify activity. It has been reported that 
bioactive peptides or small proteins are highly influenced 
by their molecular weight and structure, which are 
affected by the isolation process; different approaches for 
isolation can lead to different bioactive agents (Guo-fang 
et al., 2011; Wang et al., 2012).  
In the present study, the in vitro antiproliferative activity 
of protein extracts from C. fluctifraga was evaluated for 
the first time, the importance of these results is evidenced 
by previous reports of many anticancer chemical entities 
found by the screening of natural sources, such as 
marine organisms. Our results suggest that protein 
extracts from C. fluctifraga could induce cellular growth 
inhibition against HeLa and MDA-MB-231 cells, however 
further studies are needed. 
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